Pimavanserin (Nuplazid (r) ) has been approved for the treatment of Parkinson-related psychosis.
This is new. Hitherto, more or less all effective treatments options blocked
dopamine, which leads to a worsening of Parkinson.
This drug has a new mechanism of action.
I will keep you aupdated, once it becomes available in Europe.